About Chrestos
Chrestos is a Healthcare company based in Essen (Germany) founded in 2006, and was acquired by Buenavista Equity Partners Portugal in November 2024. Pharmacokinetic and pharmacodynamic study services are offered by this CRO. The company has 54 employees. Chrestos offers products and services including CRO Services and Green Initiatives Consulting. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Pharmacometrics. Its legal entity is Chrestos Concept GmbH & Co. KG.
Company details
Chrestos was established in 2006 and is headquartered in Essen, Germany. Operations are centered on contract research organization activities within the pharmaceutical sector. Pharmacokinetic and pharmacodynamic studies are conducted to support drug development processes. Services encompass study design, execution, and data analysis for clients in the biotech and pharma industries. Focus is maintained on regulatory-compliant methodologies across European operations.
- Headquarters Essen, Germany
- Employees 54
- Stage Acquired
- SectorsHealthcare
- Website chrestos.de
- Social LinkedIn
- Acquired by Buenavista Equity Partners Portugal (Nov 2024)
- Legal Name Chrestos Concept Gmbh & Co. Kg
- Investors
- Employee Count54
- Acquired byBuenavista Equity Partners Portugal
(Nov 2024)
Products & Services of Chrestos
Chrestos offers a comprehensive portfolio of products and services, including CRO Services and Green Initiatives Consulting.
Provides research for medical product development and data analysis.
Offers advice on green mobility and education programs.
Investors in Chrestos
Chrestos has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Buenavista Equity Partners Portugal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in Venture, Private Equity, and Infrastructures across multiple regions. | 2021 | buenavistaequity.pt | Lisbon, Portugal |
Investor details for Chrestos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Chrestos
2 dated milestones of Chrestos across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Chrestos is founded.
- Exit Acquired by Buenavista Equity Partners Portugal.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chrestos
Complete news archive for Chrestos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chrestos
Chrestos was founded in 2006.
Chrestos is headquartered in Essen, Germany. It is registered at Essen, North Rhine-westphalia, Germany.
Chrestos has 54 employees.
Chrestos was established in 2006 and is headquartered in Essen, Germany. Operations are centered on contract research organization activities within the pharmaceutical sector. Pharmacokinetic and pharmacodynamic studies are conducted to support drug development processes. Services encompass study design, execution, and data analysis for clients in the biotech and pharma industries. Focus is maintained on regulatory-compliant methodologies across European operations.
Chrestos offers CRO Services and Green Initiatives Consulting.
Chrestos has 1 investor. Key investors include Buenavista Equity Partners Portugal.
Chrestos operates through Chrestos Concept Gmbh & Co. Kg.
Yes. Chrestos was acquired by Buenavista Equity Partners Portugal in November 2024.